Dose escalation improves therapeutic outcome: post hoc analysis of data from a 12-week, multicentre, double-blind, parallel-group trial of trospium chloride in patients with urinary urge incontinence. [PDF]
BMC Urol, 2010 Bödeker RH +3 more
europepmc +1 more source
The muscarinic receptor antagonist propiverine exhibits α(1)-adrenoceptor antagonism in human prostate and porcine trigonum. [PDF]
World J Urol, 2011 Wuest M +8 more
europepmc +1 more source
Efficacy of propiverine ER with or without α-blockers related to maximum urinary flow rate in adult men with OAB: results of a 12-week, multicenter, non-interventional study. [PDF]
World J Urol, 2011 Oelke M +4 more
europepmc +1 more source
Effect of concomitant administration of trospium chloride extended release on the steady-state pharmacokinetics of metformin in healthy adults. [PDF]
Clin Drug Investig, 2013 Oefelein MG +5 more
europepmc +1 more source
Urinary incontinence in children. [PDF]
Dtsch Arztebl Int, 2011 Schultz-Lampel D +5 more
europepmc +1 more source
Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophrenia: A Randomized Clinical Trial.
JAMA PsychiatryKaul I +8 more
europepmc +1 more source
Anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence. [PDF]
N Engl J Med, 2012 Visco AG +14 more
europepmc +1 more source
Overactive bladder disease: the urge for better therapies. [PDF]
J Manag Care Pharm, 2008 Thomas L, Culley EJ.
europepmc +1 more source
Actions of two main metabolites of propiverine (M-1 and M-2) on voltage-dependent L-type Ca2+ currents and Ca2+ transients in murine urinary bladder myocytes. [PDF]
J Pharmacol Exp Ther, 2008 Zhu HL +6 more
europepmc +1 more source
Pharmacodynamics of propiverine and three of its main metabolites on detrusor contraction. [PDF]
Br J Pharmacol, 2005 Wuest M +7 more
europepmc +1 more source